Search

for
Search:

Research

5 / 1000+ results

research Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss

17 citations , December 2013 in “Journal of Investigative Dermatology Symposium Proceedings”

In this study, once-daily treatment with bimatoprost 0.03% solution significantly increased eyelash growth, thickness, and darkness in patients with chemotherapy-induced eyelash loss compared to placebo, and was well tolerated over one year.

research 50524 Facebook groups provide support and product recommendations for patients using scalp cooling to prevent chemotherapy-induced alopecia: A survey study

September 2024 in “Journal of the American Academy of Dermatology”

This study reports that cancer patients experiencing chemotherapy-induced alopecia actively engage in Facebook groups for support, instructions, and product recommendations related to scalp cooling, but only 5% consult dermatologists for hair loss concerns, highlighting the platform's influence on patient treatment decisions.

research Lifestyle and Adiponectin Level: Four-Year Follow-up of Controlled Trials

5 citations , July 2010 in “Archives of Internal Medicine”

This study observed that topical prostaglandin treatments may protect against hair follicle injury during chemotherapy, as indicated by preserved eyelashes in patients using these treatments.

research Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials

March 2025 in “JAAD reviews.”

This review found that bimatoprost effectively treats chemotherapy-induced eyelash loss, known as milphosis, in cancer patients, as demonstrated in three small trials, but further research is needed due to limitations like small sample sizes and short follow-up periods.